Concepedia

Elizabeth Fisher

EF

Statistics

Publications

76

Citations

9.3K

H-Index

43

Active since

1951

Affiliations

Cleveland Clinic(Current)

Biogen (United States)

Cleveland Clinic Lerner College of Medicine

McGill University

Montreal Neurological Institute and Hospital

Elizabeth Fisher is an author at Cleveland Clinic specializing in neurology, multiple sclerosis, and medicine.

Publications per year

1951–2025

76

Publications

76

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Jeffrey Cohen, Alasdair Coles, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations

Life Sciences, Immunology, Neurology +11

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Alasdair Coles, Cary Twyman, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations · Full text

Life Sciences, Immunology, Neurology +11

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS

Richard A. Rudick, Elizabeth Fisher, J.-C. Lee et al. · Neurology · 1999 · 737 citations · Full text

Life Sciences, Neurology, Neuroscience +13

Gray matter atrophy in multiple sclerosis: A longitudinal study

Elizabeth Fisher, Jar‐Chi Lee, Kunio Nakamura et al. · Annals of Neurology · 2008 · 673 citations

Life Sciences, Neurology, Neuroscience +17

Eight-year follow-up study of brain atrophy in patients with MS

Elizabeth Fisher, Richard A. Rudick, Jack H. Simon et al. · Neurology · 2002 · 377 citations

Medicine, Neurology, Neuroscience +15

1–5 of 76